[
    [
        {
            "time": "",
            "original_text": "复星医药2020年净利润增长10%，承认采购的国外疫苗存在瑕疵，已被封存！",
            "features": {
                "keywords": [
                    "复星医药",
                    "净利润增长",
                    "疫苗",
                    "瑕疵",
                    "封存"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "复星医药2020年净利润增长10%，承认采购的国外疫苗存在瑕疵，已被封存！",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]